Protagonist Therapeutics Inc (PTGX)
33.39
-0.96
(-2.79%)
USD |
NASDAQ |
Jun 14, 16:00
33.37
-0.02
(-0.06%)
After-Hours: 20:00
Protagonist Therapeutics 30-Day Average Daily Volume: 583376.8 for June 14, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| June 14, 2024 | 583376.8 |
| June 13, 2024 | 587171.5 |
| June 12, 2024 | 594537.2 |
| June 11, 2024 | 599472.9 |
| June 10, 2024 | 583127.9 |
| June 07, 2024 | 564514.8 |
| June 06, 2024 | 547126.7 |
| June 05, 2024 | 526087.1 |
| June 04, 2024 | 496317.9 |
| June 03, 2024 | 493189.8 |
| May 31, 2024 | 490506.8 |
| May 30, 2024 | 490177.0 |
| May 29, 2024 | 489727.2 |
| May 28, 2024 | 484167.0 |
| May 24, 2024 | 484396.9 |
| May 23, 2024 | 493812.0 |
| May 22, 2024 | 490178.7 |
| May 21, 2024 | 494593.8 |
| May 20, 2024 | 513215.4 |
| May 17, 2024 | 513977.1 |
| May 16, 2024 | 512449.8 |
| May 15, 2024 | 522771.7 |
| May 14, 2024 | 522084.3 |
| May 13, 2024 | 528444.0 |
| May 10, 2024 | 538483.1 |
| Date | Value |
|---|---|
| May 09, 2024 | 543152.3 |
| May 08, 2024 | 535151.3 |
| May 07, 2024 | 519578.4 |
| May 06, 2024 | 517103.6 |
| May 03, 2024 | 517841.5 |
| May 02, 2024 | 525520.9 |
| May 01, 2024 | 522537.2 |
| April 30, 2024 | 513689.7 |
| April 29, 2024 | 524429.9 |
| April 26, 2024 | 553407.6 |
| April 25, 2024 | 572520.0 |
| April 24, 2024 | 572692.5 |
| April 23, 2024 | 577217.1 |
| April 22, 2024 | 585348.9 |
| April 19, 2024 | 601739.4 |
| April 18, 2024 | 614896.7 |
| April 17, 2024 | 617921.5 |
| April 16, 2024 | 618972.0 |
| April 15, 2024 | 618649.3 |
| April 12, 2024 | 634399.7 |
| April 11, 2024 | 635585.0 |
| April 10, 2024 | 637659.7 |
| April 09, 2024 | 629123.3 |
| April 08, 2024 | 610551.8 |
| April 05, 2024 | 609763.5 |
30-Day Average Daily Volume Range, Past 5 Years
131214.0
Minimum
May 07 2020
3.674M
Maximum
Oct 28 2021
773554.1
Average
637083.8
Median
Oct 06 2023
30-Day Average Daily Volume Benchmarks
| Lifecore Biomedical Inc | 156519.0 |
| SELLAS Life Sciences Group Inc | 844405.0 |
| Akebia Therapeutics Inc | 2.580M |
| BridgeBio Pharma Inc | 1.571M |
| Moderna Inc | 4.348M |